GLP-1 Shortage Alternatives: Costs When Ozempic or Zepbound Aren't Available — cost infographic

GLP-1 Shortage Alternatives: Costs When Ozempic or Zepbound Aren't Available

{ if eq .Lang "zh" }{ else }
✓ Reviewed by Dr. Michael Torres, MD, FACS · Bariatric Surgeon ✓ Sources: ASMBS, CDC, CMS, NCQA ✓ Updated 2025–2026
{ end }

What do you do when your pharmacy says your Zepbound prescription is on backorder — again? For a period between 2022 and 2024, this was a recurring reality for millions of patients as GLP-1 medications sat on the FDA’s official drug shortage list amid unprecedented demand.

Here’s what your realistic alternatives cost, ranked from cheapest to most involved.

Step 1: Confirm the Shortage Status

Before assuming the worst, check the FDA’s drug shortage database directly. Shortages are sometimes specific to certain doses or delivery devices (like a particular pen size) rather than the medication entirely — your prescriber may be able to switch you to an available strength without switching medications at all.

Alternative Options and Their Costs

AlternativeEstimated Monthly CostTypical Effectiveness vs. GLP-1
Switch to a different GLP-1 (e.g., Wegovy to Saxenda)$1,000 – $1,400Comparable to lower, depending on drug
Phentermine (older stimulant-based medication)$30 – $80More modest average weight loss
Phentermine-topiramate (Qsymia)$100 – $250Moderate, better than phentermine alone
Contrave (naltrexone-bupropion)$100 – $300Moderate
Compounded GLP-1 (where legally available)$150 – $500Comparable if properly dosed
Medically supervised weight loss program alone$150 – $400Lower, but no medication access risk
Bariatric surgery$15,000 – $28,000 (one-time)Highest, most durable

Why Shortages Happened in the First Place

Demand for semaglutide and tirzepatide-based medications surged dramatically starting in 2022 as GLP-1 drugs gained mainstream popularity for weight loss beyond their original diabetes indication. Manufacturers couldn’t scale production fast enough to meet demand, triggering official FDA shortage designations that lasted, in tirzepatide’s case, into 2024 before supply caught up.

Ask About Manufacturer Coupon and Savings Programs

Even during periods when a specific GLP-1 medication is in short supply, manufacturers sometimes prioritize allocation to patients enrolled in their official savings or patient assistance programs. Enroll before you’re in crisis mode — it can improve both your cost and your access priority when supply is tight.

Older Medications Aren’t Obsolete

Phentermine, approved by the FDA since 1959, remains one of the most prescribed weight-loss medications in the country precisely because it’s inexpensive, widely available, and effective for short-term use. It won’t match GLP-1 medications for average weight loss, but as a bridge option during a shortage — or for patients who can’t access or afford GLP-1 drugs long-term — it remains clinically relevant. See our phentermine cost guide for full pricing detail.

When Surgery Becomes the More Reliable Option

For patients who’ve experienced repeated medication access disruptions — or who face an indefinite monthly cost they can’t sustain — bariatric surgery offers something GLP-1 medications structurally can’t: a result that doesn’t depend on continued prescription availability or insurance formulary changes. Research from the NIH indicates most patients who stop GLP-1 medications regain a substantial share of lost weight within a year, a dependency risk that doesn’t apply the same way to surgical outcomes.

Don’t attempt to stretch a GLP-1 prescription by skipping doses or taking a lower dose than prescribed to make a limited supply last longer. Inconsistent dosing can reduce effectiveness and, in some cases, worsen side effects when you resume your full prescribed dose. Talk to your prescriber about a supply gap before improvising your own dosing schedule.

Making the Comparison for Yourself

If shortage instability has you reconsidering your long-term weight-loss strategy, our GLP-1 versus surgery cost comparison breaks down the 5-year and 10-year cost trajectories for both paths side by side.

{ if eq .Lang "zh" }
费用与医疗免责声明:本页所列价格为美国市场估算数据,来源于公开数据及2025年减重手术行业调查。实际费用因手术类型、医院及保险状态不同而存在差异。 本内容仅供参考,不构成专业医疗建议。请咨询持牌减重外科医生后再做手术决定。
{ else }

Disclaimer: BariatricCostGuide provides cost data for educational purposes only. We are not a medical provider, insurance company, or financial advisor. All costs are estimates based on published data and vary by location, facility, surgeon, insurance plan, and individual health factors. Consult a board-certified bariatric surgeon and your insurance carrier for personalized medical and cost advice.

{ end }